-
Carbon-Ion Radiotherapy, Ferroptosis, and DHODH
2026-09-15
Wang and Cai report that carbon-ion radiotherapy suppresses DHODH, increases ferroptosis-associated stress in gastric cancer cells, and promotes an M1-like macrophage phenotype through tumor-conditioned medium. The study connects radiation response with tumor-cell redox biology and macrophage polarization, while identifying DHODH as a potential mechanistic modifier rather than establishing a clinically ready treatment strategy.
-
KX2-391 Dihydrochloride in CRC Metastasis Assays
2026-09-15
KX2-391 dihydrochloride offers a mechanistically informed way to interrogate SRC-dependent colorectal cancer metastasis. This guide translates the FGF19–ELF4–FGFR4–SRC findings into assay design decisions while defining the compound’s cross-domain research boundaries.
-
Protease Inhibitor Cocktail for Plant Signal Fidelity
2026-09-14
Discover how a Protease Inhibitor Cocktail preserves the molecular evidence behind NSP2–MYB40 research, from plant cell protein stability to interaction assays. This guide presents an assay-centered strategy for reducing protein degradation without obscuring biologically meaningful results.
-
Liraglutide and the Brain–Kidney AVP Axis
2026-09-14
Greenwood and colleagues combine a human before-and-after study with rat pituitary proteomics, phosphoproteomics, functional AVP reporter experiments, and renal signaling analysis to explain how liraglutide may alter fluid homeostasis. The study links reduced circulating arginine vasopressin to sex- and time-dependent synaptic regulation and downstream aquaporin 2 changes, while highlighting the need to separate reporter activity from direct molecular abundance.
-
Applied 4-Ethylphenyl Sulfate Workflows
2026-09-13
Build reproducible renal biomarker, gut microbiota-brain interaction, and adsorption assays with 4-ethylphenyl sulfate. This guide connects compound handling to matrix-aware quantitation, behavioral model design, and practical troubleshooting.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-12
A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, inhibited cell-cycle progression and tumor growth, and achieved bladder-localized expression with limited transient systemic distribution in mice.
-
Ajugol, Mitophagy, and Pyroptosis in Gout
2026-09-12
A recent study identifies impaired PINK1/Parkin-dependent mitophagy as a mechanistic link between mitochondrial stress and chondrocyte pyroptosis in acute gouty arthritis. Using computational analysis, cell experiments, pharmacologic pathway controls, and a mouse model, the authors show that ajugol suppresses PI3K/AKT/mTOR signaling, restores mitochondrial quality control, and reduces cartilage inflammation.
-
EdU Imaging Kits (Cy5) for Mitochondrial Quality Control
2026-09-11
EdU Imaging Kits (Cy5) provide a precise S-phase readout for connecting cell proliferation with mitochondrial clearance during myogenic differentiation. This article explains how EdU pulse design, imaging, and flow cytometry can distinguish altered proliferation from mitochondrial stress or apoptosis.
-
Adefovir Population PK and OAT1 Phenotyping
2026-09-11
This 2024 study applies population pharmacokinetic modeling to explain how Adefovir behaves as an OAT1 probe within a transporter cocktail. Its findings separate a modest absorption or prodrug-conversion effect from renal transporter activity and support renal clearance as a practical OAT1 phenotyping metric.
-
Cy5 Maleimide for Protein Condensate Imaging
2026-09-10
Cy5 maleimide enables selective cysteine labeling for protein tracking, condensate partitioning assays, and red-shifted fluorescence readouts. This guide connects solvent-aware conjugation and purification with the electrostatic partitioning principles revealed in recent α-synuclein condensate research.
-
H 89 2HCl for PKA Signaling Workflows
2026-09-10
H 89 2HCl enables controlled interrogation of PKA-dependent phosphorylation, calcium signaling, and neurite phenotypes without directly lowering cAMP. This guide translates its use into practical neuronal workflows, matched rescue experiments, and troubleshooting strategies that address solvent, dose, and off-target risks.
-
KX2-391 Dihydrochloride: Applied Workflows
2026-09-09
KX2-391 dihydrochloride, also called Tirbanibulin dihydrochloride, connects Src-substrate-site inhibition with disruption of tubulin polymerization, enabling orthogonal oncology assays rather than a single-pathway readout. This guide translates image-based screening, viability testing, HBV transcription studies, and BoNT/A assays into practical workflows with concentration ranges, controls, and troubleshooting decisions.
-
Thiazole Src Inhibitors: Insights from KX2-391
2026-09-09
The reference study developed thiazole-based N-benzyl acetamide analogs to examine how scaffold replacement and benzyl substitution influence Src-associated activity and cancer-cell proliferation. Its results identify compound 8a as a cellular Src inhibitor and 8b as a promising antiproliferative analog, while also illustrating the limitations of inferring mechanism from cell-based assays alone.
-
WRN–MMR Synthetic Lethality in MSI CRC
2026-09-08
The reference study explains why mismatch repair-deficient, microsatellite-instability colorectal cancer cells depend on Werner helicase: WRN loss activates a p53/PUMA apoptotic program. Genetic and pharmacological experiments, including ML216 treatment, show that this vulnerability can suppress MSI colorectal cancer growth, particularly when p53 remains functional.
-
Tranexamic Acid in Fibrinolysis Research
2026-09-07
Tranexamic Acid provides a concentration-controlled route to investigate clot stabilization, plasmin activity, and neutrophil–endothelial interactions. This guide translates its antifibrinolytic mechanism into practical assays and connects the compound to a bi-layer wound-dressing study that combined rapid hemostasis with antibacterial performance.